Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Psychological Research|October 6, 2023
Over ninety years old: Does high cognitive reserve still help brain efficiency?Elisa Carta, Alice Riccardi, Silvia Marinetto, et al.
Frontiers in Neurology|May 24, 2021
Brain Volume and Perception of Cognitive Impairment in People With Multiple Sclerosis and Their CaregiversGiuseppe Fenu, Lorena Lorefice, Elisa Carta, et al.
Frontiers in Neurology|July 15, 2021
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot StudyAlice Riccardi, Francesca Ognibene, Sara Mondini, et al.
European Journal of Medicinal Chemistry|January 18, 2018
Quinoxaline derivatives as new inhibitors of coxsackievirus B5Antonio Carta, Giuseppina Sanna, Irene Briguglio, et al.
Nature Communications|September 3, 2025
Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairmentAnnalaura Lerede, Alexandra Moura, Valentina Giunchiglia, et al.
Marine Environmental Research|December 30, 2025
Wildfire ash undermines the physiology of the Mediterranean coral Cladocora caespitosaEnrico Montalbetti, Davide Seveso, Simone Farina, et al.
Frontiers in Immunology|December 27, 2021
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis PatientsMaristella Pitzalis, Maria Laura Idda, Valeria Lodde, et al.
Frontiers in Immunology|September 5, 2022
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up studyMaria Laura Idda, Maristella Pitzalis, Valeria Lodde, et al.
Frontiers in Immunology|July 30, 2024
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccinationValeria Orrù, Valentina Serra, Michele Marongiu, et al.
Pageof 1